Evidence map›Paper›PMID 38954051›Full record

ArticleInternational ophthalmology2024

Chasing the objective upper eyelid symmetry formula; R

Kubra Serefoglu Cabuk, Said Kemal Cengiz, Mehmet Guray Guler, Husna Topcu, Ayse Cetin Efe, Mehmet Goksel Ulas, Fatma Poslu Karademir

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kubra Serefoglu CabukDepartment of Ophthalmology, University of Health Sciences Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. drqubra@gmail.com.
Said Kemal CengizDefence Technologies, Istanbul Technical University, Istanbul, Turkey.
Mehmet Guray GulerDepartment of Industrial Engineering, Faculty of Management, Istanbul Technical University, Istanbul, Turkey.
Husna TopcuUniversity of Health Sciences Beyoglu Eye Hospital, Istanbul, Turkey.
Ayse Cetin EfeUniversity of Health Sciences Beyoglu Eye Hospital, Istanbul, Turkey.
Mehmet Goksel UlasUniversity of Health Sciences Beyoglu Eye Hospital, Istanbul, Turkey.
Fatma Poslu KarademirUniversity of Health Sciences Beyoglu Eye Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInvestigate the most appropriate mathematical formula to objectively express upper eyelid contour symmetry.

methods62 eyes of 31 patients were included in the study. The upper eyelid contour symmetry of the patients was classified subjectively (independent of MRD1) as poor, acceptable, and good by three oculoplastic specialists (senior, expert, and junior surgeon). Bézier curves of the upper lid contour were drawn with ImageJ software (NIH, Bethesda, MA, USA). Using the algorithms created by Author SKC in Spyder (Python 3.7.9.), the symmetry of the Bézier curves of the left eyelids were obtained according to the y-axis, and the mid-pupils of both eyes were superimposed. The lower curve moved vertically to the equal height of the other curve to equalize MRD1's. R

resultsThe correlation coefficient of RMSE and MSE were the same for all surgeons grading. There was a strong correlation between the senior surgeon's subjective scoring (N; poor = 8, acceptable = 16, good = 8) and R

conclusionsRMSE, MSE, POC, MAE, and especially R

Indexed as

EyelidsAdultAgedAlgorithmsBlepharoplastyFemaleHumansMaleMiddle AgedMAEMSEPOCR2RMSESymmetryUpper eyelid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.